Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study
about
Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study.Neutrophil extracellular traps - the dark side of neutrophils.Proprotein convertase subtilisin/kexin type 9 (PCSK9) Deficiency is Protective Against Venous Thrombosis in Mice.Statins as a preventative therapy for venous thromboembolism.
P2860
Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Is lipid lowering therapy an i ...... ation-based case-control study
@ast
Is lipid lowering therapy an i ...... ation-based case-control study
@en
type
label
Is lipid lowering therapy an i ...... ation-based case-control study
@ast
Is lipid lowering therapy an i ...... ation-based case-control study
@en
prefLabel
Is lipid lowering therapy an i ...... ation-based case-control study
@ast
Is lipid lowering therapy an i ...... ation-based case-control study
@en
P2093
P2860
P1433
P1476
Is lipid lowering therapy an i ...... ation-based case-control study
@en
P2093
Aneel A Ashrani
Daniel J Crusan
John A Heit
Kent R Bailey
Michel K Barsoum
Tanya M Petterson
P2860
P304
P356
10.1016/J.THROMRES.2015.04.005
P577
2015-04-11T00:00:00Z